Is the price fair?
What BAX's price assumes
Baxter International did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 0.76× revenue.
0.76
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.43
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 1.43
- EV / EBIToperating margin −2.6%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $10.3B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #20 of 27 by Smart Score